D-Index & Metrics Best Publications
Immunology
Israel
2023

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 96 Citations 33,971 421 World Ranking 501 National Ranking 6
Medicine D-index 102 Citations 39,674 557 World Ranking 4499 National Ranking 11

Research.com Recognitions

Awards & Achievements

2023 - Research.com Immunology in Israel Leader Award

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Disease
  • Virus

His primary scientific interests are in Pediatrics, Vaccination, Immunology, Virology and Incidence. His studies deal with areas such as Surgery, Epidemiology, Cohort study, Rubella and Etiology as well as Pediatrics. His Vaccination research is multidisciplinary, relying on both Internal medicine and Confidence interval.

His research brings together the fields of Meningococcal disease and Immunology. His Virology research incorporates elements of Carriage, Seroprevalence and Young adult. His biological study spans a wide range of topics, including Influenza A virus and Pandemic.

His most cited work include:

  • Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000–17: a prospective national observational cohort study (205 citations)
  • Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study. (196 citations)
  • Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England. (180 citations)

What are the main themes of his work throughout his whole career to date?

Nick Andrews mostly deals with Vaccination, Pediatrics, Immunology, Virology and Epidemiology. His research integrates issues of Internal medicine, Confidence interval and Immunization in his study of Vaccination. His research in Pediatrics intersects with topics in Incidence, Measles, Pneumococcal conjugate vaccine, Disease and Public health.

His Public health course of study focuses on Cohort and Cohort study. As a part of the same scientific study, Nick Andrews usually deals with the Immunology, concentrating on Meningococcal disease and frequently concerns with Meningococcal vaccine and Tetanus. His work investigates the relationship between Epidemiology and topics such as Outbreak that intersect with problems in Environmental health.

He most often published in these fields:

  • Vaccination (39.25%)
  • Pediatrics (36.86%)
  • Immunology (20.82%)

What were the highlights of his more recent work (between 2018-2021)?

  • Public health (16.38%)
  • Vaccination (39.25%)
  • Pediatrics (36.86%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Public health, Vaccination, Pediatrics, Internal medicine and Epidemiology. The Public health study combines topics in areas such as Incidence, Severe acute respiratory syndrome coronavirus 2, Asymptomatic, Pandemic and Cohort. The study incorporates disciplines such as Pertussis vaccine, Titer and Confidence interval in addition to Vaccination.

Nick Andrews performs multidisciplinary studies into Pediatrics and Booster in his work. His Internal medicine study incorporates themes from Coinfection and Meningococcal vaccine. The Epidemiology study which covers Disease that intersects with Group B.

Between 2018 and 2021, his most popular works were:

  • Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study. (196 citations)
  • Excess all-cause mortality during the COVID-19 pandemic in Europe - preliminary pooled estimates from the EuroMOMO network, March to April 2020. (53 citations)
  • Emergence of a Novel Coronavirus (COVID-19): Protocol for Extending Surveillance Used by the Royal College of General Practitioners Research and Surveillance Centre and Public Health England. (44 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Virus

Nick Andrews mainly focuses on Public health, Internal medicine, Pandemic, Pediatrics and Vaccination. Nick Andrews combines subjects such as Intensive care medicine, Cohort, Family medicine and Medical emergency with his study of Public health. His studies examine the connections between Internal medicine and genetics, as well as such issues in Influenza vaccine, with regards to Influenza a and Primary care.

His Pediatrics study combines topics from a wide range of disciplines, such as Epidemiology and Disease. His Epidemiology research incorporates themes from Meningitis and Incidence. The concepts of his Vaccination study are interwoven with issues in Rotavirus vaccine, Intussusception, Increased risk and Confidence interval.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.

Jamielopez L. Bernal;Nick Andrews;Charlotte Gower;Eileen Gallagher.
The New England Journal of Medicine (2021)

1653 Citations

Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study

Elizabeth Miller;Katja Hoschler;Pia Hardelid;Elaine Stanford.
The Lancet (2010)

861 Citations

Effectiveness of maternal pertussis vaccination in England: an observational study

Gayatri Amirthalingam;Nick Andrews;Helen Campbell;Sonia Ribeiro.
The Lancet (2014)

774 Citations

Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study

Elizabeth Miller;Nicholas J Andrews;Pauline A Waight;Mary P E Slack.
Lancet Infectious Diseases (2011)

719 Citations

Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction.

Caroline L Trotter;Nick J Andrews;Edward B Kaczmarski;Elizabeth Miller.
The Lancet (2004)

717 Citations

Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study.

James Lopez Bernal;James Lopez Bernal;James Lopez Bernal;Nicholas Andrews;Nicholas Andrews;Charlotte Gower;Chris Robertson.
BMJ (2021)

665 Citations

Population‐based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40

Wendy A. Knowles;Pam Pipkin;Nick Andrews;Andrew Vyse.
Journal of Medical Virology (2003)

598 Citations

Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study

Pauline A Waight;Nicholas J Andrews;Shamez N Ladhani;Carmen L Sheppard.
Lancet Infectious Diseases (2015)

569 Citations

Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis

Mary E Ramsay;Nick J Andrews;Caroline L Trotter;Edward B Kaczmarski.
BMJ (2003)

520 Citations

Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity

Martin C. J. Maiden;Ana Belén Ibarz-Pavón;Rachel Urwin;Stephen J. Gray.
The Journal of Infectious Diseases (2008)

494 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Nick Andrews

Andrew J. Pollard

Andrew J. Pollard

University of Oxford

Publications: 111

Ray Borrow

Ray Borrow

Manchester Royal Infirmary

Publications: 99

Mary Ramsay

Mary Ramsay

Public Health England

Publications: 94

Shamez N. Ladhani

Shamez N. Ladhani

Public Health England

Publications: 93

Richard Pebody

Richard Pebody

Public Health England

Publications: 85

Elizabeth Miller

Elizabeth Miller

Public Health England

Publications: 70

Matthew D. Snape

Matthew D. Snape

University of Oxford

Publications: 50

Paul T. Heath

Paul T. Heath

St George's, University of London

Publications: 49

Guy A. M. Berbers

Guy A. M. Berbers

University of Minnesota

Publications: 44

Shabir A. Madhi

Shabir A. Madhi

University of the Witwatersrand

Publications: 43

David Goldblatt

David Goldblatt

University College London

Publications: 42

Maria Zambon

Maria Zambon

Public Health England

Publications: 42

Peter McIntyre

Peter McIntyre

University of Otago

Publications: 39

Mary P. E. Slack

Mary P. E. Slack

Griffith University

Publications: 37

Ron Dagan

Ron Dagan

Ben-Gurion University of the Negev

Publications: 35

Adam Finn

Adam Finn

University of Bristol

Publications: 35

Trending Scientists

Pingzhi Fan

Pingzhi Fan

Southwest Jiaotong University

Dimitris Kiritsis

Dimitris Kiritsis

École Polytechnique Fédérale de Lausanne

Vincenzo Spagnolo

Vincenzo Spagnolo

Polytechnic University of Bari

J. David Carlson

J. David Carlson

Lord Corporation (United States)

David D. Thomas

David D. Thomas

University of Minnesota

Peter F. Nelson

Peter F. Nelson

Macquarie University

Weishu Liu

Weishu Liu

Southern University of Science and Technology

Robert F. Davis

Robert F. Davis

Carnegie Mellon University

Richard Villems

Richard Villems

University of Tartu

Julia Ostner

Julia Ostner

University of Göttingen

David L. Harmon

David L. Harmon

University of Kentucky

Tadaomi Takenawa

Tadaomi Takenawa

Kobe University

Stan Gronthos

Stan Gronthos

University of Adelaide

Timothy S. Baker

Timothy S. Baker

University of California, San Diego

Tomohisa Kuzuyama

Tomohisa Kuzuyama

University of Tokyo

Mark E. Feinberg

Mark E. Feinberg

Pennsylvania State University

Something went wrong. Please try again later.